Outset Medical, Inc.
OM
$14.20
$0.533.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 119.30M | 115.27M | 113.69M | 114.73M | 116.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 119.30M | 115.27M | 113.69M | 114.73M | 116.43M |
| Cost of Revenue | 75.23M | 73.28M | 74.24M | 78.76M | 83.12M |
| Gross Profit | 44.08M | 41.99M | 39.45M | 35.97M | 33.30M |
| SG&A Expenses | 92.80M | 100.17M | 109.18M | 118.20M | 129.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 192.72M | 202.59M | 218.55M | 238.11M | 261.42M |
| Operating Income | -73.42M | -87.32M | -104.86M | -123.38M | -145.00M |
| Income Before Tax | -97.51M | -113.37M | -127.49M | -140.33M | -158.67M |
| Income Tax Expenses | 397.00K | 444.00K | 491.00K | 607.00K | 511.00K |
| Earnings from Continuing Operations | -97.90 | -113.82 | -127.98 | -140.94 | -159.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -97.90M | -113.82M | -127.98M | -140.94M | -159.18M |
| EBIT | -73.42M | -87.32M | -104.86M | -123.38M | -145.00M |
| EBITDA | -68.17M | -81.75M | -99.14M | -117.61M | -139.15M |
| EPS Basic | -20.30 | -29.22 | -37.33 | -41.56 | -47.14 |
| Normalized Basic EPS | -10.97 | -16.52 | -21.71 | -24.84 | -28.35 |
| EPS Diluted | -20.30 | -29.22 | -37.33 | -41.56 | -47.14 |
| Normalized Diluted EPS | -10.97 | -16.52 | -21.71 | -24.84 | -28.35 |
| Average Basic Shares Outstanding | 31.66M | 17.38M | 13.73M | 13.57M | 13.53M |
| Average Diluted Shares Outstanding | 31.66M | 17.38M | 13.73M | 13.57M | 13.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |